Literature DB >> 17965290

Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens.

Jason D Gardner1, Gregory L Brower, Tetyana G Voloshenyuk, Joseph S Janicki.   

Abstract

Intact female rats fed a high-phytoestrogen diet are protected against adverse left ventricular (LV) remodeling induced by chronic volume overload. We hypothesized that both phytoestrogens and ovarian hormones, particularly estrogen, are necessary for this dietary-induced cardioprotection. To test this hypothesis, eight groups of female rats were studied; rats were fed either a high-phytoestrogen (+phyto) or phytoestrogen-free diet. Groups included sham-operated rats, intact rats with fistula (Fist), ovariectomized rats with fistula (Fist-OX), and Fist-OX rats treated with estrogen (EST). Myocardial function and remodeling were assessed after 8 wk of volume overload using a blood-perfused isolated heart apparatus. Fist-OX rats developed significant ventricular dilatation and increased compliance vs. intact Fist rats, which were associated with a significant decrease in contractility. Estrogen treatment prevented pulmonary edema and attenuated LV hypertrophy and dilatation but did not maintain contractility. However, dietary phytoestrogens completely prevented LV dilatation in both the Fist+phyto and Fist-OX+EST+phyto groups but had no effect on LV remodeling in the Fist-OX+phyto group. Contractility was significantly greater in the estrogen-treated rats fed the phytoestrogen diet than in those treated with estrogen alone. Dietary phytoestrogens did not affect LV or uterine mass, serum estrogen, LV estrogen receptor expression, or cardiac function in sham animals. These data indicate that estrogen is not solely responsible for the cardioprotection exhibited by intact females and that phytoestrogens can work synergistically with ovarian hormones to attenuate ventricular remodeling induced by chronic volume overload in female rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965290     DOI: 10.1152/ajpheart.00281.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  22 in total

1.  Estrogenic modulation of inflammation-related genes in male rats following volume overload.

Authors:  Jennifer L McLarty; Giselle C Meléndez; Scott P Levick; Shanté Bennett; Tara Sabo-Attwood; Gregory L Brower; Joseph S Janicki
Journal:  Physiol Genomics       Date:  2012-01-24       Impact factor: 3.107

Review 2.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

3.  Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.

Authors:  Jianping Li; Shaiban Jubair; Joseph S Janicki
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

4.  Tropomyosin dephosphorylation results in compensated cardiac hypertrophy.

Authors:  Emily M Schulz; Richard N Correll; Hajer N Sheikh; Marco S Lofrano-Alves; Patti L Engel; Gilbert Newman; Jo El J Schultz; Jeffery D Molkentin; Beata M Wolska; R John Solaro; David F Wieczorek
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

Review 5.  Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase.

Authors:  Joseph S Janicki; Francis G Spinale; Scott P Levick
Journal:  Pflugers Arch       Date:  2013-02-16       Impact factor: 3.657

6.  New frontiers in heart hypertrophy during pregnancy.

Authors:  Jingyuan Li; Soban Umar; Marjan Amjedi; Andrea Iorga; Salil Sharma; Rangarajan D Nadadur; Vera Regitz-Zagrosek; Mansoureh Eghbali
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

7.  Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype.

Authors:  Hong Lu; Giselle C Meléndez; Scott P Levick; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-09       Impact factor: 4.733

8.  Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload.

Authors:  Yan Du; Eric Plante; Joseph S Janicki; Gregory L Brower
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

Review 9.  Gender Differences in Cardiac Hypertrophy.

Authors:  Jian Wu; Fangjie Dai; Chang Li; Yunzeng Zou
Journal:  J Cardiovasc Transl Res       Date:  2019-08-15       Impact factor: 4.132

10.  Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts.

Authors:  Jason D Gardner; David B Murray; Tetyana G Voloshenyuk; Gregory L Brower; Jessica M Bradley; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.